KEM Evang,klinkiken Essen -mitte-gg Pharmaceutical Import Profile — Germany (DGFT 2022–2026)

Name: KEM Evang,klinkiken Essen -mitte-gg Pharmaceutical Import Records from India — 2 Products, $1.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

KEM Evang,klinkiken Essen -mitte-gg — Pharmaceutical Importer Profile (2026) | 2 Products, $1.0M Trade | TransData Nexus

Who Are the Verified Indian Suppliers to KEM Evang,klinkiken Essen -mitte-gg?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Greenship Exports	$895.4K	63	100.0%

KEM Evang,klinkiken Essen -mitte-gg sources from 1 verified Indian supplier across 21 distinct formulations. The sourcing is highly concentrated — Greenship Exports accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does KEM Evang,klinkiken Essen -mitte-gg Import?

Formulation	Value	Ships
Balaswagandhadi tailam ( lut	$101.7K	3
Baladhathryadi tailam ( lut	$100.7K	3
Kshirabalatailam ( lut	$100.6K	3
Dhanwantaram tailam ( lut	$98.7K	3
Thriphaladi tailam ( lut	$62.3K	3
Mahabala tailam ( lut	$60.1K	3
Murivenna ( lut -ad320422001371z	$60.1K	3
Valiya prasarani tailam ( lut	$58.0K	3
Himasagara tailam ( lut	$53.7K	3
Valiya narayana tailam ( lut	$49.4K

KEM Evang,klinkiken Essen -mitte-gg imports 21 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

What Products Does KEM Evang,klinkiken Essen -mitte-gg Import?

Top Products by Import Value

1Taila$987.5K 2Ghrita$17.2K

KEM Evang,klinkiken Essen -mitte-gg Therapeutic Categories — 1 Specializations

KEM Evang,klinkiken Essen -mitte-gg imports across 1 therapeutic categories, with Ayurvedic & Herbal Products (100.0%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Ayurvedic & Herbal Products

2 products · 100.0% · $1.0M

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Taila	Ayurvedic & Herbal Products	$987.5K	39	13.0%	2
2	Ghrita	Ayurvedic & Herbal Products	$17.2K	6	3.7%	2

Key Metrics

Total Import Value$1.0M

Products2

Shipments45

Categories1

CountryGermany

#1 Rankings0

Indian Suppliers1

Formulations21

Top Categories

Ayurvedic & Herbal Products100.0%

Indian Suppliers

Last updated: March 28, 2026

KEM Evang,klinkiken Essen -mitte-gg — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

KEM I Evang. Kliniken Essen-Mitte gGmbH, established in 1975, is a prominent healthcare provider in the Ruhr region of Germany. Operating three hospital sites in Essen—Evang. Huyssens-Stiftung, Evang. Krankenhaus Essen-Steele, and Evang. Krankenhaus Essen-Werden—the organization offers a comprehensive range of medical services across 22 specialized departments. With approximately 1,000 planned beds and a workforce of around 2,700 employees, KEM Essen-Mitte is recognized as a leading medical institution in the area.

The organization is structured as a non-profit limited liability company (gGmbH), reflecting its commitment to reinvesting resources into patient care and medical advancements. Its mission centers on providing patient care based on the latest scientific standards and the highest levels of medical and nursing quality. This dedication has earned KEM Essen-Mitte multiple accolades, underscoring its status among Germany's top clinics. (medi-karriere.de)

2Distribution Network

KEM I Evang. Kliniken Essen-Mitte gGmbH operates three hospital sites in Essen, Germany:

Supplier Relationship Intelligence — KEM Evang,klinkiken Essen -mitte-gg

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

KEM I Evang. Kliniken Essen-Mitte gGmbH's pharmaceutical imports from India are exclusively sourced from a single supplier, GREENSHIP EXPORTS, accounting for 100% of their Indian pharmaceutical imports. This indicates a high level of supplier concentration, which could pose risks such as supply chain disruptions or dependency on a single source. However, the consistent volume of shipments—63 in total—suggests a stable and reliable relationship between KEM Essen-Mitte and GREENSHIP EXPORTS. The total import value of $895K reflects a significant investment in these imports, highlighting the importance of this supplier to the organization's pharmaceutical procurement strategy.

2Supply Chain Resilience

The resilience of KEM I Evang. Kliniken Essen-Mitte gGmbH's supply chain is closely tied to its exclusive reliance on GREENSHIP EXPORTS for pharmaceutical imports from India. This single-source dependency may expose the organization to risks such as supply chain disruptions or changes in supplier reliability. The lack of publicly available information regarding backup suppliers or alternative sourcing strategies suggests a potential area for improvement in diversifying the supply chain to enhance resilience. Additionally, the diversity of formulations imported and the exposure to specific shipping routes are not detailed, making it challenging to fully assess the supply chain's robustness.

3Strategic Implications

The exclusive sourcing pattern from GREENSHIP EXPORTS positions KEM I Evang. Kliniken Essen-Mitte gGmbH as highly dependent on a single supplier for its pharmaceutical needs. This concentration could impact the organization's competitive position, especially if alternative suppliers offer more favorable terms or innovative products. For Indian exporters, this presents an opportunity to introduce alternative suppliers to KEM Essen-Mitte, potentially diversifying the hospital's supply chain and reducing dependency on a single source. Engaging with KEM Essen-Mitte could lead to strategic partnerships, provided that the exporters can meet the hospital's quality standards and supply requirements.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into Germany — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Germany

1Regulatory Authority & Framework

In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) is the primary regulatory authority overseeing pharmaceutical imports. Key legislation governing pharma imports includes the Medicines Act (AMG), which sets forth requirements for the importation, distribution, and marketing of medicinal products. The marketing authorization pathway for Indian generics involves obtaining approval from BfArM, ensuring that imported generics meet German standards for safety, efficacy, and quality. This process includes comprehensive documentation and compliance with Good Manufacturing Practice (GMP) standards.

2Import Licensing & GMP

Import licensing requirements for pharmaceuticals in Germany necessitate that foreign manufacturers hold a valid GMP certificate recognized by the European Union, WHO, or PIC/S. Indian exporters must ensure that their manufacturing facilities comply with these standards to facilitate the importation of their products into Germany. Additionally, wholesalers must obtain authorization from the competent German authorities, which involves demonstrating compliance with regulatory requirements and maintaining appropriate storage and distribution conditions.

3Quality & Labeling

Pharmaceutical products imported into Germany must undergo batch testing to verify their quality and safety. Stability requirements ensure that products maintain their efficacy throughout their shelf life. Labeling must be in German, providing clear information on usage, dosage, and safety precautions. Serialization mandates are in place to track and trace pharmaceutical products, enhancing supply chain security and preventing counterfeit products from entering the market.

4Recent Regulatory Changes

Between 2024 and 2026, Germany has implemented several policy changes affecting pharmaceutical imports, including stricter compliance with EU GMP standards and enhanced serialization requirements. These changes aim to improve patient safety and product traceability. Indian pharmaceutical exporters must stay informed about these regulatory updates to ensure continued access to the German market.

TransData Nexus Research · Germany regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: KEM Evang,klinkiken Essen -mitte-gg identified across shipments using consignee name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as KEM Evang,klinkiken Essen -mitte-gg's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 45 individual customs records matching KEM Evang,klinkiken Essen -mitte-gg.
5.Supplier Verification: KEM Evang,klinkiken Essen -mitte-gg sources from 1 verified Indian suppliers across 21 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2 Products Tracked

1 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

KEM Evang,klinkiken Essen -mitte-gg

KEM Evang,klinkiken Essen -mitte-gg — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to KEM Evang,klinkiken Essen -mitte-gg?

What Formulations Does KEM Evang,klinkiken Essen -mitte-gg Import?

What Products Does KEM Evang,klinkiken Essen -mitte-gg Import?

Top Products by Import Value

KEM Evang,klinkiken Essen -mitte-gg Therapeutic Categories — 1 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Indian Suppliers

KEM Evang,klinkiken Essen -mitte-gg — Corporate Profile & Information

1Company Overview

2Distribution Network

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — KEM Evang,klinkiken Essen -mitte-gg

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Germany — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

KEM Evang,klinkiken Essen -mitte-gg — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to KEM Evang,klinkiken Essen -mitte-gg

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — KEM Evang,klinkiken Essen -mitte-gg

What products does KEM Evang,klinkiken Essen -mitte-gg import from India?

Who supplies pharmaceuticals to KEM Evang,klinkiken Essen -mitte-gg from India?

What is KEM Evang,klinkiken Essen -mitte-gg's total pharmaceutical import value?

What therapeutic categories does KEM Evang,klinkiken Essen -mitte-gg focus on?

Get Full KEM Evang,klinkiken Essen -mitte-gg Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology